Results 1 to 10 of about 25,697 (255)

Calculation of Royalties in Compulsory Licensing of Pharmaceutical Patents in Europe – How Much is Justified?

Nordic Journal of Commercial Law, 2011
Rent-seeking companies are not aiming at increasing the quantity of capital services that their asset yields in certain period of time, but rather at investing in intangibles with the objective of gaining high returns in the future.
Elli Välimäki
doaj   +2 more sources

Claim Interpretation in Use-Limited Product Inventions: Focusing on Seoul Central District Court Case 2018GaHab579509

Journal of Intellectual Property
The court ruling adopted the Supreme Court’s principle that in inventions for pharmaceutical uses, the specific use should be considered an element of a claim.
Seungkwan Jwa
doaj   +1 more source

A relação entre patentes farmacêuticas e programas públicos de saúde

Cadernos de Campo, 2012
This paper discusses how the patent was set up mainly relating to the pharmaceutical sector since 1995 with the implementation of the TRIPS agreement.
José Flávio de Castro
doaj  

In Defense of Secondary Pharmaceutical Patents in Drug Discovery and Development. [PDF]

ACS Med Chem Lett, 2020
Agranat I, Marom H.
europepmc   +1 more source

In Defense of Secondary Pharmaceutical Patents: A Response to the UN's Guidelines for Pharmaceutical Patent Examination

Indiana Law Review, 2017
In 2015 the United Nations Development Programme issued a document entitled Guidelines for Pharmaceutical Patent Examination: Examining Pharmaceutical Patents from a Public Health Perspective (the “Guidelines”). The heart of the Guidelines is a category-by-category examination of eight types of “secondary” pharmaceutical patent claims: Markush claims ...
openaire   +2 more sources

Pharmaceutical patents: reconciling the human right to health with the incentive to invent. [PDF]

Drug Discov Today, 2020
Khachigian LM.
europepmc   +1 more source

Patent protection of pharmaceuticals.

Acta poloniae pharmaceutica, 2001
Patenting of biologically active compounds by academic institutions is discussed, with emphasis on patents for already known compounds.
openaire   +1 more source

Shari‘ah Treatment of Paradox between Access to Medicine and Global Pharmaceutical Patents under TRIPS Agreement 1994

Pakistan Journal of Islamic Research, 2018
This paper contributes to existing debate on issue of access to essential lifesaving medicine in result of global pharmaceutical patent protection standards.
Muhammad Danyal Khan, Rais Nouman Ahmed
doaj  

TRIPS, pharmaceutical patents, and generic competition in India. [PDF]

Health Aff Sch
Kyle MK, Sampat BN, Shadlen KC.
europepmc   +1 more source

AI-assisted interpretation of Markush structures in pharmaceutical patents: a review of emerging tools, datasets, and challenges. [PDF]

J Cheminform
Hayes JMU, Olawode EO, Andy A, Ameyaw EE.   +3 more
europepmc   +1 more source